γ9δ2 T-Cell Expansion and Phenotypic Profile Are Reflected in the CDR3δ Repertoire of Healthy Adults

被引:3
|
作者
Vyborova, Anna [1 ]
Janssen, Anke [1 ]
Gatti, Lucrezia [1 ]
Karaiskaki, Froso [1 ]
Yonika, Austin [1 ]
van Dooremalen, Sanne [1 ]
Sanders, Jasper [1 ]
Beringer, Dennis X. [1 ]
Straetemans, Trudy [1 ,2 ]
Sebestyen, Zsolt [1 ]
Kuball, Juergen [1 ,2 ]
机构
[1] Univ Utrecht, Univ Med Ctr UMC Utrecht, Ctr Translat Immunol, Utrecht, Netherlands
[2] Univ Utrecht, Univ Med Ctr UMC Utrecht, Dept Hematol, Utrecht, Netherlands
来源
FRONTIERS IN IMMUNOLOGY | 2022年 / 13卷
关键词
human gamma 9 delta 2 T cells; CDR3; delta; adult V delta 2 repertoire; differentiation profile; public clonotypes; NKG2D; CD94/NKG2A(B); RECEPTORS; LYMPHOCYTES; RECOGNITION; EXPRESSION; TCR; ACTIVATION; GENERATION; SELECTION; SUBSETS; REGIONS;
D O I
10.3389/fimmu.2022.915366
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
gamma 9 delta 2T cells fill a distinct niche in human immunity due to the unique physiology of the phosphoantigen-reactive gamma 9 delta 2TCR. Here, we highlight reproducible TCR delta complementarity-determining region 3 (CDR3 delta) repertoire patterns associated with gamma 9 delta 2T cell proliferation and phenotype, thus providing evidence for the role of the CDR3 delta in modulating in vivo T-cell responses. Features that determine gamma 9 delta 2TCR binding affinity and reactivity to the phosphoantigen-induced ligand in vitro appear to similarly underpin in vivo clonotypic expansion and differentiation. Likewise, we identify a CDR3 delta bias in the gamma 9 delta 2T cell natural killer receptor (NKR) landscape. While expression of the inhibitory receptor CD94/NKG2A is skewed toward cells bearing putative high-affinity TCRs, the activating receptor NKG2D is expressed independently of the phosphoantigen-sensing determinants, suggesting a higher net NKR activating signal in T cells with TCRs of low affinity. This study establishes consistent repertoire-phenotype associations and justifies stratification for the T-cell phenotype in future research on gamma 9 delta 2TCR repertoire dynamics.
引用
收藏
页数:13
相关论文
共 50 条
  • [31] Delayed recovery of CDR3 complexity of the T-cell receptor-β chain in recipients of allogeneic bone marrow transplants who had virus-associated interstitial pneumonia:: Monitor of T-cell function by CDR3 spectratyping
    Hirokawa, M
    Horiuchi, T
    Kitabayashi, A
    Kawabata, Y
    Matsutani, T
    Suzuki, R
    Chihara, J
    Miura, AB
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2000, 106 (01) : S32 - S39
  • [32] CIRCULATING T-CELL REPERTOIRE COMPLEXITY IN NORMAL INDIVIDUALS AND BONE-MARROW RECIPIENTS ANALYZED BY CDR3 SIZE SPECTRATYPING - CORRELATION WITH IMMUNE STATUS
    GORSKI, J
    YASSAI, M
    ZHU, XL
    KISSELLA, B
    KEEVER, C
    FLOMENBERG, N
    JOURNAL OF IMMUNOLOGY, 1994, 152 (10): : 5109 - 5119
  • [33] CDR3δ-grafted γ9δ2T cells mediate effective antitumor reactivity
    Zhao, Hui
    Xi, Xueyan
    Cui, Lianxian
    He, Wei
    CELLULAR & MOLECULAR IMMUNOLOGY, 2012, 9 (02) : 147 - 154
  • [34] Restricted T-cell receptor (TCR) β chain repertoire following T-cell depleted allogeneic transplantation and partial reconstitution following donor lymphocyte infusion as studied by the CDR3 length analysis.
    Munshi, N
    Mitani, Y
    Schichman, SA
    Butch, A
    Rosen, N
    Fink, LM
    Vesole, D
    Singhal, S
    Desikan, R
    Siegel, D
    Mehta, J
    Barlogie, B
    Lue, C
    BLOOD, 1998, 92 (10) : 358B - 358B
  • [35] CDR3δ -grafted γ9δ2T cells mediate effective antitumor reactivity
    Hui Zhao
    Xueyan Xi
    Lianxian Cui
    Wei He
    Cellular & Molecular Immunology, 2012, 9 : 147 - 154
  • [36] Cysteine and hydrophobic residues in CDR3 serve as distinct T-cell self-reactivity indices
    Daley, Stephen R.
    Koay, Hui-Fern
    Dobbs, Kerry
    Bosticardo, Marita
    Wirasinha, Rushika C.
    Pala, Francesca
    Castagnoli, Riccardo
    Rowe, Jared H.
    de Bruin, Lisa M. Ott
    Keles, Sevgi
    Lee, Yu Nee
    Somech, Raz
    Holland, Steven M.
    Delmonte, Ottavia M.
    Draper, Debbie
    Maxwell, Sandra
    Niemela, Julie
    Stoddard, Jennifer
    Rosenzweig, Sergio D.
    Poliani, Pietro Luigi
    Capo, Valentina
    Villa, Anna
    Godfrey, Dale I.
    Notarangelo, Luigi D.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2019, 144 (01) : 333 - 336
  • [37] mRNA-Based Anti-TCR CDR3 Tumour Vaccine for T-Cell Lymphoma
    Tusup, Marina
    Laeuchli, Severin
    Jarzebska, Natalia Teresa
    French, Lars E.
    Chang, Yun-Tsan
    Vonow-Eisenring, Maya
    Su, Andreas
    Kuendig, Thomas M.
    Guenova, Emmanuella
    Pascolo, Steve
    PHARMACEUTICS, 2021, 13 (07)
  • [38] TCR-engineered T-cell therapy through personalized identification of CDR3 clonotypes.
    Zhou, Zishan
    Pu, Yue
    Xiao, Shanshan
    Wang, Ping
    Yu, Yang
    Lin, Rui
    Wang, Tao
    Jiao, Shun Chang
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [39] Restriction of the T-cell repertoire in tumor-infiltrating lymphocytes from nine patients with renal-cell carcinoma. Relevance of the CDR3 length analysis for the identification of in situ clonal T-cell expansions
    Puisieux, I
    Bain, C
    Merrouche, Y
    Malacher, P
    Kourilsky, P
    Even, J
    Favrot, M
    INTERNATIONAL JOURNAL OF CANCER, 1996, 66 (02) : 201 - 208
  • [40] Unique CDR3 epitope targeting by CAR-T cells is a viable approach for treating T-cell malignancies
    Jinqi Huang
    Stepanov Alexey
    Jian Li
    Terri Jones
    Geramie Grande
    Lacey Douthit
    Jun Xie
    Danna Chen
    Xiaolei Wu
    Maschan Michael
    Changchun Xiao
    Jiangning Zhao
    Xuehua Xie
    Jia Xie
    Xiao Lei Chen
    Guo Fu
    Gabibov Alexander
    Chi-Meng Tzeng
    Leukemia, 2019, 33 : 2315 - 2319